▶ 調査レポート

クリティカルケアサービスの世界市場(~2026年)

• 英文タイトル:Global Critical Care Services Market Size, Status and Forecast 2020-2026

QYResearchが調査・発行した産業分析レポートです。クリティカルケアサービスの世界市場(~2026年) / Global Critical Care Services Market Size, Status and Forecast 2020-2026 / MRC2-11QY11528資料のイメージです。• レポートコード:MRC2-11QY11528
• 出版社/出版日:QYResearch / 2020年11月25日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、128ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:ヘルスケア
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Multi User¥865,800 (USD5,850)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料はクリティカルケアサービスのグローバル市場について調査・分析したレポートです。種類別(人工呼吸器、血圧計、アラーム、その他)市場規模、用途別(中枢神経系障害、循環障害、ショック、代謝、呼吸不全)市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別クリティカルケアサービスの競争状況、市場シェア
・世界のクリティカルケアサービス市場:種類別市場規模 2015年-2020年(人工呼吸器、血圧計、アラーム、その他)
・世界のクリティカルケアサービス市場:種類別市場規模予測 2021年-2026年(人工呼吸器、血圧計、アラーム、その他)
・世界のクリティカルケアサービス市場:用途別市場規模 2015年-2020年(中枢神経系障害、循環障害、ショック、代謝、呼吸不全)
・世界のクリティカルケアサービス市場:用途別市場規模予測 2021年-2026年(中枢神経系障害、循環障害、ショック、代謝、呼吸不全)
・北米のクリティカルケアサービス市場分析:米国、カナダ
・ヨーロッパのクリティカルケアサービス市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのクリティカルケアサービス市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のクリティカルケアサービス市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのクリティカルケアサービス市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):BioMed Central、CSL Behring、Takeda、Grifols、Kedrion Biopharma、Octapharma、Bayer HealthCare、Merck、Mitsubishi Tanabe Pharma、REVO Biologics、Rockwell Medical、Thermo Fisher Scientific、Shanghai RAAS、China Biologic Products、Cosmo Pharmaceuticals、King Pharmaceuticals
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Market Analysis and Insights: Global Critical Care Services Market
The global Critical Care Services market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Critical Care Services Scope and Market Size
Critical Care Services market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Critical Care Services market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
BioMed Central
CSL Behring
Takeda
Grifols
Kedrion Biopharma
Octapharma
Bayer HealthCare
Merck
Mitsubishi Tanabe Pharma
REVO Biologics
Rockwell Medical
Thermo Fisher Scientific
Shanghai RAAS
China Biologic Products
Cosmo Pharmaceuticals
King Pharmaceuticals

Market segment by Type, the product can be split into
Ventilator
Sphygmomanometer
Alarm
Other
Market segment by Application, split into
Central Nervous System Failure
Circulatory Failure
Shock
Metabolic
Respiratory Failure

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Critical Care Services Revenue
1.4 Market by Type
1.4.1 Global Critical Care Services Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Ventilator
1.4.3 Sphygmomanometer
1.4.4 Alarm
1.4.5 Other
1.5 Market by Application
1.5.1 Global Critical Care Services Market Share by Application: 2020 VS 2026
1.5.2 Central Nervous System Failure
1.5.3 Circulatory Failure
1.5.4 Shock
1.5.5 Metabolic
1.5.6 Respiratory Failure
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Critical Care Services Market Perspective (2015-2026)
2.2 Global Critical Care Services Growth Trends by Regions
2.2.1 Critical Care Services Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Critical Care Services Historic Market Share by Regions (2015-2020)
2.2.3 Critical Care Services Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Critical Care Services Market Growth Strategy
2.3.6 Primary Interviews with Key Critical Care Services Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Critical Care Services Players by Market Size
3.1.1 Global Top Critical Care Services Players by Revenue (2015-2020)
3.1.2 Global Critical Care Services Revenue Market Share by Players (2015-2020)
3.1.3 Global Critical Care Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Critical Care Services Market Concentration Ratio
3.2.1 Global Critical Care Services Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Critical Care Services Revenue in 2019
3.3 Critical Care Services Key Players Head office and Area Served
3.4 Key Players Critical Care Services Product Solution and Service
3.5 Date of Enter into Critical Care Services Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Critical Care Services Historic Market Size by Type (2015-2020)
4.2 Global Critical Care Services Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Critical Care Services Market Size by Application (2015-2020)
5.2 Global Critical Care Services Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Critical Care Services Market Size (2015-2020)
6.2 Critical Care Services Key Players in North America (2019-2020)
6.3 North America Critical Care Services Market Size by Type (2015-2020)
6.4 North America Critical Care Services Market Size by Application (2015-2020)

7 Europe
7.1 Europe Critical Care Services Market Size (2015-2020)
7.2 Critical Care Services Key Players in Europe (2019-2020)
7.3 Europe Critical Care Services Market Size by Type (2015-2020)
7.4 Europe Critical Care Services Market Size by Application (2015-2020)

8 China
8.1 China Critical Care Services Market Size (2015-2020)
8.2 Critical Care Services Key Players in China (2019-2020)
8.3 China Critical Care Services Market Size by Type (2015-2020)
8.4 China Critical Care Services Market Size by Application (2015-2020)

9 Japan
9.1 Japan Critical Care Services Market Size (2015-2020)
9.2 Critical Care Services Key Players in Japan (2019-2020)
9.3 Japan Critical Care Services Market Size by Type (2015-2020)
9.4 Japan Critical Care Services Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Critical Care Services Market Size (2015-2020)
10.2 Critical Care Services Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Critical Care Services Market Size by Type (2015-2020)
10.4 Southeast Asia Critical Care Services Market Size by Application (2015-2020)

11 India
11.1 India Critical Care Services Market Size (2015-2020)
11.2 Critical Care Services Key Players in India (2019-2020)
11.3 India Critical Care Services Market Size by Type (2015-2020)
11.4 India Critical Care Services Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Critical Care Services Market Size (2015-2020)
12.2 Critical Care Services Key Players in Central & South America (2019-2020)
12.3 Central & South America Critical Care Services Market Size by Type (2015-2020)
12.4 Central & South America Critical Care Services Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 BioMed Central
13.1.1 BioMed Central Company Details
13.1.2 BioMed Central Business Overview
13.1.3 BioMed Central Critical Care Services Introduction
13.1.4 BioMed Central Revenue in Critical Care Services Business (2015-2020))
13.1.5 BioMed Central Recent Development
13.2 CSL Behring
13.2.1 CSL Behring Company Details
13.2.2 CSL Behring Business Overview
13.2.3 CSL Behring Critical Care Services Introduction
13.2.4 CSL Behring Revenue in Critical Care Services Business (2015-2020)
13.2.5 CSL Behring Recent Development
13.3 Takeda
13.3.1 Takeda Company Details
13.3.2 Takeda Business Overview
13.3.3 Takeda Critical Care Services Introduction
13.3.4 Takeda Revenue in Critical Care Services Business (2015-2020)
13.3.5 Takeda Recent Development
13.4 Grifols
13.4.1 Grifols Company Details
13.4.2 Grifols Business Overview
13.4.3 Grifols Critical Care Services Introduction
13.4.4 Grifols Revenue in Critical Care Services Business (2015-2020)
13.4.5 Grifols Recent Development
13.5 Kedrion Biopharma
13.5.1 Kedrion Biopharma Company Details
13.5.2 Kedrion Biopharma Business Overview
13.5.3 Kedrion Biopharma Critical Care Services Introduction
13.5.4 Kedrion Biopharma Revenue in Critical Care Services Business (2015-2020)
13.5.5 Kedrion Biopharma Recent Development
13.6 Octapharma
13.6.1 Octapharma Company Details
13.6.2 Octapharma Business Overview
13.6.3 Octapharma Critical Care Services Introduction
13.6.4 Octapharma Revenue in Critical Care Services Business (2015-2020)
13.6.5 Octapharma Recent Development
13.7 Bayer HealthCare
13.7.1 Bayer HealthCare Company Details
13.7.2 Bayer HealthCare Business Overview
13.7.3 Bayer HealthCare Critical Care Services Introduction
13.7.4 Bayer HealthCare Revenue in Critical Care Services Business (2015-2020)
13.7.5 Bayer HealthCare Recent Development
13.8 Merck
13.8.1 Merck Company Details
13.8.2 Merck Business Overview
13.8.3 Merck Critical Care Services Introduction
13.8.4 Merck Revenue in Critical Care Services Business (2015-2020)
13.8.5 Merck Recent Development
13.9 Mitsubishi Tanabe Pharma
13.9.1 Mitsubishi Tanabe Pharma Company Details
13.9.2 Mitsubishi Tanabe Pharma Business Overview
13.9.3 Mitsubishi Tanabe Pharma Critical Care Services Introduction
13.9.4 Mitsubishi Tanabe Pharma Revenue in Critical Care Services Business (2015-2020)
13.9.5 Mitsubishi Tanabe Pharma Recent Development
13.10 REVO Biologics
13.10.1 REVO Biologics Company Details
13.10.2 REVO Biologics Business Overview
13.10.3 REVO Biologics Critical Care Services Introduction
13.10.4 REVO Biologics Revenue in Critical Care Services Business (2015-2020)
13.10.5 REVO Biologics Recent Development
13.11 Rockwell Medical
10.11.1 Rockwell Medical Company Details
10.11.2 Rockwell Medical Business Overview
10.11.3 Rockwell Medical Critical Care Services Introduction
10.11.4 Rockwell Medical Revenue in Critical Care Services Business (2015-2020)
10.11.5 Rockwell Medical Recent Development
13.12 Thermo Fisher Scientific
10.12.1 Thermo Fisher Scientific Company Details
10.12.2 Thermo Fisher Scientific Business Overview
10.12.3 Thermo Fisher Scientific Critical Care Services Introduction
10.12.4 Thermo Fisher Scientific Revenue in Critical Care Services Business (2015-2020)
10.12.5 Thermo Fisher Scientific Recent Development
13.13 Shanghai RAAS
10.13.1 Shanghai RAAS Company Details
10.13.2 Shanghai RAAS Business Overview
10.13.3 Shanghai RAAS Critical Care Services Introduction
10.13.4 Shanghai RAAS Revenue in Critical Care Services Business (2015-2020)
10.13.5 Shanghai RAAS Recent Development
13.14 China Biologic Products
10.14.1 China Biologic Products Company Details
10.14.2 China Biologic Products Business Overview
10.14.3 China Biologic Products Critical Care Services Introduction
10.14.4 China Biologic Products Revenue in Critical Care Services Business (2015-2020)
10.14.5 China Biologic Products Recent Development
13.15 Cosmo Pharmaceuticals
10.15.1 Cosmo Pharmaceuticals Company Details
10.15.2 Cosmo Pharmaceuticals Business Overview
10.15.3 Cosmo Pharmaceuticals Critical Care Services Introduction
10.15.4 Cosmo Pharmaceuticals Revenue in Critical Care Services Business (2015-2020)
10.15.5 Cosmo Pharmaceuticals Recent Development
13.16 King Pharmaceuticals
10.16.1 King Pharmaceuticals Company Details
10.16.2 King Pharmaceuticals Business Overview
10.16.3 King Pharmaceuticals Critical Care Services Introduction
10.16.4 King Pharmaceuticals Revenue in Critical Care Services Business (2015-2020)
10.16.5 King Pharmaceuticals Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Critical Care Services Key Market Segments
Table 2. Key Players Covered: Ranking by Critical Care Services Revenue
Table 3. Ranking of Global Top Critical Care Services Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Critical Care Services Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Ventilator
Table 6. Key Players of Sphygmomanometer
Table 7. Key Players of Alarm
Table 8. Key Players of Other
Table 9. Global Critical Care Services Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Critical Care Services Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Critical Care Services Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Critical Care Services Market Share by Regions (2015-2020)
Table 13. Global Critical Care Services Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Critical Care Services Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Critical Care Services Market Growth Strategy
Table 19. Main Points Interviewed from Key Critical Care Services Players
Table 20. Global Critical Care Services Revenue by Players (2015-2020) (Million US$)
Table 21. Global Critical Care Services Market Share by Players (2015-2020)
Table 22. Global Top Critical Care Services Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Critical Care Services as of 2019)
Table 23. Global Critical Care Services by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Critical Care Services Product Solution and Service
Table 26. Date of Enter into Critical Care Services Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Critical Care Services Market Size by Type (2015-2020) (Million US$)
Table 29. Global Critical Care Services Market Size Share by Type (2015-2020)
Table 30. Global Critical Care Services Revenue Market Share by Type (2021-2026)
Table 31. Global Critical Care Services Market Size Share by Application (2015-2020)
Table 32. Global Critical Care Services Market Size by Application (2015-2020) (Million US$)
Table 33. Global Critical Care Services Market Size Share by Application (2021-2026)
Table 34. North America Key Players Critical Care Services Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Critical Care Services Market Share (2019-2020)
Table 36. North America Critical Care Services Market Size by Type (2015-2020) (Million US$)
Table 37. North America Critical Care Services Market Share by Type (2015-2020)
Table 38. North America Critical Care Services Market Size by Application (2015-2020) (Million US$)
Table 39. North America Critical Care Services Market Share by Application (2015-2020)
Table 40. Europe Key Players Critical Care Services Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Critical Care Services Market Share (2019-2020)
Table 42. Europe Critical Care Services Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Critical Care Services Market Share by Type (2015-2020)
Table 44. Europe Critical Care Services Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Critical Care Services Market Share by Application (2015-2020)
Table 46. China Key Players Critical Care Services Revenue (2019-2020) (Million US$)
Table 47. China Key Players Critical Care Services Market Share (2019-2020)
Table 48. China Critical Care Services Market Size by Type (2015-2020) (Million US$)
Table 49. China Critical Care Services Market Share by Type (2015-2020)
Table 50. China Critical Care Services Market Size by Application (2015-2020) (Million US$)
Table 51. China Critical Care Services Market Share by Application (2015-2020)
Table 52. Japan Key Players Critical Care Services Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Critical Care Services Market Share (2019-2020)
Table 54. Japan Critical Care Services Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Critical Care Services Market Share by Type (2015-2020)
Table 56. Japan Critical Care Services Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Critical Care Services Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Critical Care Services Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Critical Care Services Market Share (2019-2020)
Table 60. Southeast Asia Critical Care Services Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Critical Care Services Market Share by Type (2015-2020)
Table 62. Southeast Asia Critical Care Services Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Critical Care Services Market Share by Application (2015-2020)
Table 64. India Key Players Critical Care Services Revenue (2019-2020) (Million US$)
Table 65. India Key Players Critical Care Services Market Share (2019-2020)
Table 66. India Critical Care Services Market Size by Type (2015-2020) (Million US$)
Table 67. India Critical Care Services Market Share by Type (2015-2020)
Table 68. India Critical Care Services Market Size by Application (2015-2020) (Million US$)
Table 69. India Critical Care Services Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Critical Care Services Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Critical Care Services Market Share (2019-2020)
Table 72. Central & South America Critical Care Services Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Critical Care Services Market Share by Type (2015-2020)
Table 74. Central & South America Critical Care Services Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Critical Care Services Market Share by Application (2015-2020)
Table 76. BioMed Central Company Details
Table 77. BioMed Central Business Overview
Table 78. BioMed Central Product
Table 79. BioMed Central Revenue in Critical Care Services Business (2015-2020) (Million US$)
Table 80. BioMed Central Recent Development
Table 81. CSL Behring Company Details
Table 82. CSL Behring Business Overview
Table 83. CSL Behring Product
Table 84. CSL Behring Revenue in Critical Care Services Business (2015-2020) (Million US$)
Table 85. CSL Behring Recent Development
Table 86. Takeda Company Details
Table 87. Takeda Business Overview
Table 88. Takeda Product
Table 89. Takeda Revenue in Critical Care Services Business (2015-2020) (Million US$)
Table 90. Takeda Recent Development
Table 91. Grifols Company Details
Table 92. Grifols Business Overview
Table 93. Grifols Product
Table 94. Grifols Revenue in Critical Care Services Business (2015-2020) (Million US$)
Table 95. Grifols Recent Development
Table 96. Kedrion Biopharma Company Details
Table 97. Kedrion Biopharma Business Overview
Table 98. Kedrion Biopharma Product
Table 99. Kedrion Biopharma Revenue in Critical Care Services Business (2015-2020) (Million US$)
Table 100. Kedrion Biopharma Recent Development
Table 101. Octapharma Company Details
Table 102. Octapharma Business Overview
Table 103. Octapharma Product
Table 104. Octapharma Revenue in Critical Care Services Business (2015-2020) (Million US$)
Table 105. Octapharma Recent Development
Table 106. Bayer HealthCare Company Details
Table 107. Bayer HealthCare Business Overview
Table 108. Bayer HealthCare Product
Table 109. Bayer HealthCare Revenue in Critical Care Services Business (2015-2020) (Million US$)
Table 110. Bayer HealthCare Recent Development
Table 111. Merck Business Overview
Table 112. Merck Product
Table 113. Merck Company Details
Table 114. Merck Revenue in Critical Care Services Business (2015-2020) (Million US$)
Table 115. Merck Recent Development
Table 116. Mitsubishi Tanabe Pharma Company Details
Table 117. Mitsubishi Tanabe Pharma Business Overview
Table 118. Mitsubishi Tanabe Pharma Product
Table 119. Mitsubishi Tanabe Pharma Revenue in Critical Care Services Business (2015-2020) (Million US$)
Table 120. Mitsubishi Tanabe Pharma Recent Development
Table 121. REVO Biologics Company Details
Table 122. REVO Biologics Business Overview
Table 123. REVO Biologics Product
Table 124. REVO Biologics Revenue in Critical Care Services Business (2015-2020) (Million US$)
Table 125. REVO Biologics Recent Development
Table 126. Rockwell Medical Company Details
Table 127. Rockwell Medical Business Overview
Table 128. Rockwell Medical Product
Table 129. Rockwell Medical Revenue in Critical Care Services Business (2015-2020) (Million US$)
Table 130. Rockwell Medical Recent Development
Table 131. Thermo Fisher Scientific Company Details
Table 132. Thermo Fisher Scientific Business Overview
Table 133. Thermo Fisher Scientific Product
Table 134. Thermo Fisher Scientific Revenue in Critical Care Services Business (2015-2020) (Million US$)
Table 135. Thermo Fisher Scientific Recent Development
Table 136. Shanghai RAAS Company Details
Table 137. Shanghai RAAS Business Overview
Table 138. Shanghai RAAS Product
Table 139. Shanghai RAAS Revenue in Critical Care Services Business (2015-2020) (Million US$)
Table 140. Shanghai RAAS Recent Development
Table 141. China Biologic Products Company Details
Table 142. China Biologic Products Business Overview
Table 143. China Biologic Products Product
Table 144. China Biologic Products Revenue in Critical Care Services Business (2015-2020) (Million US$)
Table 145. China Biologic Products Recent Development
Table 146. Cosmo Pharmaceuticals Company Details
Table 147. Cosmo Pharmaceuticals Business Overview
Table 148. Cosmo Pharmaceuticals Product
Table 149. Cosmo Pharmaceuticals Revenue in Critical Care Services Business (2015-2020) (Million US$)
Table 150. Cosmo Pharmaceuticals Recent Development
Table 151. King Pharmaceuticals Company Details
Table 152. King Pharmaceuticals Business Overview
Table 153. King Pharmaceuticals Product
Table 154. King Pharmaceuticals Revenue in Critical Care Services Business (2015-2020) (Million US$)
Table 155. King Pharmaceuticals Recent Development
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Critical Care Services Market Share by Type: 2020 VS 2026
Figure 2. Ventilator Features
Figure 3. Sphygmomanometer Features
Figure 4. Alarm Features
Figure 5. Other Features
Figure 6. Global Critical Care Services Market Share by Application: 2020 VS 2026
Figure 7. Central Nervous System Failure Case Studies
Figure 8. Circulatory Failure Case Studies
Figure 9. Shock Case Studies
Figure 10. Metabolic Case Studies
Figure 11. Respiratory Failure Case Studies
Figure 12. Critical Care Services Report Years Considered
Figure 13. Global Critical Care Services Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Critical Care Services Market Share by Regions: 2020 VS 2026
Figure 15. Global Critical Care Services Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Critical Care Services Market Share by Players in 2019
Figure 18. Global Top Critical Care Services Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Critical Care Services as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Critical Care Services Revenue in 2019
Figure 20. North America Critical Care Services Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Critical Care Services Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Critical Care Services Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Critical Care Services Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Critical Care Services Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Critical Care Services Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Critical Care Services Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Bottom-up and Top-down Approaches for This Report
Figure 28. Data Triangulation
Figure 29. Key Executives Interviewed